Post-neoadjuvant therapy lymph node response in patients with gastric adenocarcinoma
ABSTRACT Background: Neoadjuvant chemotherapy is recommended as the standard of care for eligible patients with locally advanced resectable gastric adenocarcinoma. However, given the often-late diagnosis of this tumor, understanding post-neoadjuvant therapy lymph node involvement remains a determining factor in the pro...